Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

The penicillin allergy delabeling program: A Multicenter Whole-of-Hospital health services intervention and comparative effectiveness study

Chua, K.Y.L., Vogrin, S., Bury, S., Douglas, A., Holmes, N.E., Tan, N., Brusco, N.K., Hall, R., Lambros, B., Lean, J., Stevenson, W., Devchand, M., Garrett, K., Thursky, K., Grayson, M.L., Slavin, M.A., Phillips, E.J. and Trubiano, J.A. (2020) The penicillin allergy delabeling program: A Multicenter Whole-of-Hospital health services intervention and comparative effectiveness study. Clinical Infectious Diseases, 73 (3). pp. 487-496.

Link to Published Version: https://doi.org/10.1093/cid/ciaa653
*Subscription may be required

Abstract

Background

Penicillin allergies are associated with inferior patient and antimicrobial stewardship outcomes. We implemented a whole-of-hospital program to assess the efficacy of inpatient delabeling for low-risk penicillin allergies in hospitalized inpatients.

Methods

Patients ≥ 18 years of age with a low-risk penicillin allergy were offered a single-dose oral penicillin challenge or direct label removal based on history (direct delabeling). The primary endpoint was the proportion of patients delabeled. Key secondary endpoints were antibiotic utilization pre- (index admission) and post-delabeling (index admission and 90 days).

Results

Between 21 January 2019 and 31 August 2019, we assessed 1791 patients reporting 2315 antibiotic allergies, 1225 with a penicillin allergy. Three hundred fifty-five patients were delabeled: 161 by direct delabeling and 194 via oral penicillin challenge. Ninety-seven percent (194/200) of patients were negative upon oral penicillin challenge. In the delabeled patients, we observed an increase in narrow-spectrum penicillin usage (adjusted odds ratio [OR], 10.51 [95% confidence interval {CI}, 5.39–20.48]), improved appropriate antibiotic prescribing (adjusted OR, 2.13 [95% CI, 1.45–3.13]), and a reduction in restricted antibiotic usage (adjusted OR, 0.38 [95% CI, .27–.54]). In the propensity score analysis, there was an increase in narrow-spectrum penicillins (OR, 10.89 [95% CI, 5.09–23.31]) and β-lactam/β-lactamase inhibitors (OR, 6.68 [95% CI, 3.94–11.35]) and a reduction in restricted antibiotic use (OR, 0.52 [95% CI, .36–.74]) and inappropriate prescriptions (relative risk ratio, 0.43 [95% CI, .26–.72]) in the delabeled group compared with the group who retained their allergy label.

Conclusions

This health services program using a combination of direct delabeling and oral penicillin challenge resulted in significant impacts on the use of preferred antibiotics and appropriate prescribing.

Item Type: Journal Article
Murdoch Affiliation(s): Institute for Immunology and Infectious Diseases
Publisher: Oxford University Press
Copyright: © 2020 Oxford University Press
URI: http://researchrepository.murdoch.edu.au/id/eprint/61775
Item Control Page Item Control Page